| Beth E Breland, DPT | |
|
411 W North St, Poplarville, MS 39470-2203 | |
| (601) 795-2130 | |
| (601) 795-2164 |
| Full Name | Beth E Breland |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 12 Years |
| Location | 411 W North St, Poplarville, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811242589 | NPI | - | NPPES |
| 09015077 | Medicaid | MS | |
| 1033218524 | Other | MS | GROUP NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT5132 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Encore Rehabilitation, Inc | 3577462126 | 150 |
News Archive
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
A pair of scientists on the Florida campus of The Scripps Research Institute has been awarded a $2.3 million grant by the National Institutes of Health to conduct research relevant to developing new treatments for drug addiction.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
To ensure normal fetal development and prevent disease, it is crucial that certain genes are on or off in the right time intervals. Researchers in Professor Kristian Helin's group at BRIC, University of Copenhagen, have now shown how the TET1 enzyme controls the activity of our genes. The results are just published in the journal Nature.
› Verified 1 days ago
| Provider Name | Encore Rehabilitation, Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1033218524 PECOS PAC ID: 3577462126 Enrollment ID: O20121106000516 |
News Archive
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
A pair of scientists on the Florida campus of The Scripps Research Institute has been awarded a $2.3 million grant by the National Institutes of Health to conduct research relevant to developing new treatments for drug addiction.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
To ensure normal fetal development and prevent disease, it is crucial that certain genes are on or off in the right time intervals. Researchers in Professor Kristian Helin's group at BRIC, University of Copenhagen, have now shown how the TET1 enzyme controls the activity of our genes. The results are just published in the journal Nature.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Beth E Breland, DPT Po Box 8419, Biloxi, MS 39535-8087 Ph: (228) 388-5714 | Beth E Breland, DPT 411 W North St, Poplarville, MS 39470-2203 Ph: (601) 795-2130 |
News Archive
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
A pair of scientists on the Florida campus of The Scripps Research Institute has been awarded a $2.3 million grant by the National Institutes of Health to conduct research relevant to developing new treatments for drug addiction.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
To ensure normal fetal development and prevent disease, it is crucial that certain genes are on or off in the right time intervals. Researchers in Professor Kristian Helin's group at BRIC, University of Copenhagen, have now shown how the TET1 enzyme controls the activity of our genes. The results are just published in the journal Nature.
› Verified 1 days ago
Shannon Mcintosh, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Balmoral Dr Ste A, Poplarville, MS 39470 Phone: 601-746-5101 Fax: 601-746-5102 | |
Kaci L Morris, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9 Balmoral Dr Ste A, Poplarville, MS 39470 Phone: 601-746-5101 Fax: 601-746-5102 | |
Ms. Brittney Roberts Tynes, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 411 W North St, Poplarville, MS 39470 Phone: 601-795-2130 Fax: 601-795-2164 | |
Mr. Marcus Houston, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9 Balmoral Dr Ste A, Poplarville, MS 39470 Phone: 601-365-9868 | |
Poplarville Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 1403 S Main St Ste E, Poplarville, MS 39470 Phone: 601-795-6618 Fax: 601-795-6669 | |
Ryan W Woods, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1403 South Main Street,, Suite E, Poplarville, MS 39470 Phone: 601-268-5757 Fax: 601-579-5220 |